Meeder Asset Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-36
| Closed | -$9K | – | 2418 |
|
|
2020
Q2 | $9K | Hold |
36
| – | – | ﹤0.01% | 1366 |
|
|
2020
Q1 | $6K | Sell |
36
-125
| -78% | -$20.8K | ﹤0.01% | 1735 |
|
|
2019
Q4 | $47K | Sell |
161
-132
| -45% | -$38.5K | ﹤0.01% | 1036 |
|
|
2019
Q3 | $80K | Buy |
293
+240
| +453% | +$65.5K | 0.01% | 867 |
|
|
2019
Q2 | $20K | Buy |
53
+33
| +165% | +$12.5K | ﹤0.01% | 1245 |
|
|
2019
Q1 | $5K | Sell |
20
-56
| -74% | -$14K | ﹤0.01% | 1412 |
|
|
2018
Q4 | $16K | Sell |
76
-34
| -31% | -$7.16K | ﹤0.01% | 1130 |
|
|
2018
Q3 | $50K | Sell |
110
-6
| -5% | -$2.73K | ﹤0.01% | 788 |
|
|
2018
Q2 | $46.9K | Buy |
116
+95
| +452% | +$38.4K | ﹤0.01% | 771 |
|
|
2018
Q1 | $11K | Buy |
21
+10
| +91% | +$5.24K | ﹤0.01% | 1047 |
|
|
2017
Q4 | $6K | Buy |
+11
| New | +$6K | ﹤0.01% | 1279 |
|